BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11834236)

  • 1. Contraceptive efficacy and clinical performance of Nestorone implants in postpartum women.
    Massai MR; Díaz S; Quinteros E; Reyes MV; Herreros C; Zepeda A; Croxatto HB; Moo-Young AJ
    Contraception; 2001 Dec; 64(6):369-76. PubMed ID: 11834236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a single implant of elcometrine (ST-1435), a nonorally active progestin, as a long acting contraceptive for postpartum nursing women.
    Coutinho EM; Athayde C; Dantas C; Hirsch C; Barbosa I
    Contraception; 1999 Feb; 59(2):115-22. PubMed ID: 10361626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fertility regulation in nursing women. IX. Contraceptive performance, duration of lactation, infant growth, and bleeding patterns during use of progesterone vaginal rings, progestin-only pills, Norplant implants, and Copper T 380-A intrauterine devices.
    Díaz S; Zepeda A; Maturana X; Reyes MV; Miranda P; Casado ME; Peralta O; Croxatto HB
    Contraception; 1997 Oct; 56(4):223-32. PubMed ID: 9408703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parenteral administration of progestin Nestorone to lactating cynomolgus monkeys: an ideal hormonal contraceptive at lactation?
    Heikinheimo O; Ranta S; Moo-Young A; Lähteenmäki P; Gordon K
    Hum Reprod; 1999 Aug; 14(8):1993-7. PubMed ID: 10438416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of nomegestrol acetate subdermal contraceptive implant, uniplant, during lactation.
    Abdel-Aleem H; Abol-Oyoun el-S M; Shaaban MM; el-Saeed M; Shoukry M; Makhlouf A; Salem HT
    Contraception; 1996 Nov; 54(5):281-6. PubMed ID: 8934061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal rings for contraception in lactating women.
    Massai R; Díaz S; Jackanicz T; Croxatto HB
    Steroids; 2000; 65(10-11):703-7. PubMed ID: 11108880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preregistration study on the safety and contraceptive efficacy of a progesterone-releasing vaginal ring in Chilean nursing women.
    Massai R; Miranda P; Valdés P; Lavín P; Zepeda A; Casado ME; Silva MA; Fetis G; Bravo C; Chandía O; Peralta O; Croxatto HB; Díaz S
    Contraception; 1999 Jul; 60(1):9-14. PubMed ID: 10549447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contraceptives for lactating women: a comparative trial of a progesterone-releasing vaginal ring and the copper T 380A IUD.
    Sivin I; Díaz S; Croxatto HB; Miranda P; Shaaban M; Sayed EH; Xiao B; Wu SC; Du M; Alvarez F; Brache V; Basnayake S; McCarthy T; Lacarra M; Mishell DR; Koetsawang S; Stern J; Jackanicz T
    Contraception; 1997 Apr; 55(4):225-32. PubMed ID: 9179454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A detailed analysis of menstrual blood loss in women using Norplant and Nestorone progestogen-only contraceptive implants or vaginal rings.
    Fraser IS; Weisberg E; Minehan E; Johansson ED
    Contraception; 2000 Apr; 61(4):241-51. PubMed ID: 10899479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New IPPF statement on breastfeeding, fertility and post-partum contraception.
    International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
    IPPF Med Bull; 1990 Apr; 24(2):2-4. PubMed ID: 12316285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The comparative trial of TCu 380A IUD and progesterone-releasing vaginal ring used by lactating women.
    Chen JH; Wu SC; Shao WQ; Zou MH; Hu J; Cong L; Miao L; Wang C; Dong J; Gao J; Xiao BL
    Contraception; 1998 Jun; 57(6):371-9. PubMed ID: 9693396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A contraceptive subdermal implant releasing the progestin ST-1435: ovarian function, bleeding patterns, and side effects.
    Laurikka-Routti M; Haukkamaa M
    Fertil Steril; 1992 Dec; 58(6):1142-7. PubMed ID: 1459263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contraceptive implants and lactation.
    Díaz S
    Contraception; 2002 Jan; 65(1):39-46. PubMed ID: 11861054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical performance and menstrual bleeding patterns with three dosage combinations of a Nestorone progestogen/ethinyl estradiol contraceptive vaginal ring used on a bleeding-signaled regimen.
    Weisberg E; Brache V; Alvarez F; Massai R; Mishell DR; Apter D; Gale J; Sivin I; Tsong YY; Fraser IS
    Contraception; 2005 Jul; 72(1):46-52. PubMed ID: 15964292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-year performance of a Nestorone-releasing contraceptive implant: a three-center study of 300 women.
    Sivin I; Croxatto H; Bahamondes L; Brache V; Alvarez F; Massai R; Schechter J; Ranta S; Kumar N; Wu E; Tejeda AS; Reyes V; Travers E; Allen A; Moo-Young A
    Contraception; 2004 Feb; 69(2):137-44. PubMed ID: 14759619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contraceptive effects of extended lactational amenorrhoea: beyond the Bellagio Consensus.
    Short RV; Lewis PR; Renfree MB; Shaw G
    Lancet; 1991 Mar; 337(8743):715-7. PubMed ID: 1672186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trial with Nestorone subdermal contraceptive implants.
    Díaz S; Schiappacasse V; Pavez M; Zepeda A; Moo-Young AJ; Brandeis A; Lähteenmäki P; Croxatto HB
    Contraception; 1995 Jan; 51(1):33-8. PubMed ID: 7750282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development.
    Shaamash AH; Sayed GH; Hussien MM; Shaaban MM
    Contraception; 2005 Nov; 72(5):346-51. PubMed ID: 16246660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian function during use of Nestorone(R) subdermal implants.
    Brache V; Massai R; Mishell DR; Moo-Young AJ; Alvarez F; Salvatierra AM; Cochon L; Croxatto H; Robbins A; Faundes A
    Contraception; 2000 Mar; 61(3):199-204. PubMed ID: 10827334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fertility regulation in nursing women: V. Long-term influence of a low-dose combined oral contraceptive initiated at day 90 postpartum upon lactation and infant growth.
    Peralta O; Díaz S; Juez G; Herreros C; Casado ME; Salvatierra AM; Miranda P; Durán E; Croxatto HB
    Contraception; 1983 Jan; 27(1):27-38. PubMed ID: 6404597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.